These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 21681091)
41. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Atsma F; Bartelink ML; Grobbee DE; van der Schouw YT Menopause; 2006; 13(2):265-79. PubMed ID: 16645540 [TBL] [Abstract][Full Text] [Related]
42. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
43. Doubts about oestrogen therapy in postmenopausal women. Res Reprod; 1976 Jan; 8(1):1-2. PubMed ID: 12258712 [TBL] [Abstract][Full Text] [Related]
44. [Hormone replacement therapy of menopause, heart and blood vessels]. Kuttenn F; Gerson M Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629 [TBL] [Abstract][Full Text] [Related]
45. KEEPS: The Kronos Early Estrogen Prevention Study. Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727 [TBL] [Abstract][Full Text] [Related]
46. Menopause and stroke and the effects of hormonal therapy. Lobo RA Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669 [TBL] [Abstract][Full Text] [Related]
47. Sex hormones and the cardiovascular system: effects on arterial function in women. Teede HJ Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228 [TBL] [Abstract][Full Text] [Related]
48. Origins and health consequences of stress-induced ovarian dysfunction. Kaplan JR Interdiscip Top Gerontol; 2008; 36():162-85. PubMed ID: 18523378 [TBL] [Abstract][Full Text] [Related]
49. Estrogen and coronary heart disease in women. Barrett-Connor E; Bush TL JAMA; 1991 Apr; 265(14):1861-7. PubMed ID: 2005736 [TBL] [Abstract][Full Text] [Related]
50. The endocrinology of gonadal involution: menopause and andropause. Lamberts SW Ann Endocrinol (Paris); 2003 Apr; 64(2):77-81. PubMed ID: 12773935 [TBL] [Abstract][Full Text] [Related]
51. Nasal pathophysiology and its relationship to the female ovarian hormones. Philpott CM; Robinson AM; Murty GE J Otolaryngol Head Neck Surg; 2008 Aug; 37(4):540-6. PubMed ID: 19128590 [TBL] [Abstract][Full Text] [Related]
52. Endogenous sex steroid levels and cardiovascular disease in relation to the menopause: a systematic review. Crandall CJ; Barrett-Connor E Endocrinol Metab Clin North Am; 2013 Jun; 42(2):227-53. PubMed ID: 23702399 [TBL] [Abstract][Full Text] [Related]
55. Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis. Meyer MR; Haas E; Barton M Gend Med; 2008; 5 Suppl A():S19-33. PubMed ID: 18395680 [TBL] [Abstract][Full Text] [Related]
56. Current understanding of ovarian aging. Li Q; Geng X; Zheng W; Tang J; Xu B; Shi Q Sci China Life Sci; 2012 Aug; 55(8):659-69. PubMed ID: 22932881 [TBL] [Abstract][Full Text] [Related]
57. Demographic and evolutionary trends in ovarian function and aging. Laisk T; Tšuiko O; Jatsenko T; Hõrak P; Otala M; Lahdenperä M; Lummaa V; Tuuri T; Salumets A; Tapanainen JS Hum Reprod Update; 2019 Jan; 25(1):34-50. PubMed ID: 30346539 [TBL] [Abstract][Full Text] [Related]